BlueCrest Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,600
| Closed | -$230K | – | 143 |
|
|
2023
Q1 | $230K | Buy |
+4,600
| New | +$230K | 0.01% | 205 |
|
|
2022
Q3 | – | Sell |
-67,975
| Closed | -$2.53M | – | 161 |
|
|
2022
Q2 | $2.53M | Buy |
+67,975
| New | +$2.53M | 0.1% | 75 |
|
|
2021
Q3 | – | Sell |
-71,254
| Closed | -$3.05M | – | 349 |
|
|
2021
Q2 | $3.05M | Buy |
+71,254
| New | +$3.05M | 0.06% | 244 |
|
|
2021
Q1 | – | Sell |
-183,363
| Closed | -$6.59M | – | 594 |
|
|
2020
Q4 | $6.59M | Buy |
183,363
+75,614
| +70% | +$2.72M | 0.15% | 137 |
|
|
2020
Q3 | $4.12M | Buy |
+107,749
| New | +$4.12M | 0.15% | 111 |
|
|
2019
Q4 | – | Sell |
-6,426
| Closed | -$261K | – | 396 |
|
|
2019
Q3 | $261K | Buy |
+6,426
| New | +$261K | 0.02% | 397 |
|
|
2019
Q2 | – | Sell |
-31,762
| Closed | -$1.22M | – | 480 |
|
|
2019
Q1 | $1.22M | Buy |
31,762
+16,092
| +103% | +$618K | 0.05% | 257 |
|
|
2018
Q4 | $554K | Buy |
15,670
+1,317
| +9% | +$46.6K | 0.03% | 319 |
|
|
2018
Q3 | $553K | Buy |
+14,353
| New | +$553K | 0.01% | 681 |
|
|
2018
Q1 | – | Sell |
-21,259
| Closed | -$527K | – | 1463 |
|
|
2017
Q4 | $527K | Buy |
+21,259
| New | +$527K | 0.01% | 516 |
|
|
2017
Q2 | – | Sell |
-32,458
| Closed | -$807K | – | 898 |
|
|
2017
Q1 | $807K | Buy |
32,458
+9,458
| +41% | +$235K | 0.04% | 337 |
|
|
2016
Q4 | $497K | Buy |
23,000
+1,248
| +6% | +$27K | 0.03% | 436 |
|
|
2016
Q3 | $518K | Sell |
21,752
-194,345
| -90% | -$4.63M | 0.02% | 476 |
|
|
2016
Q2 | $5.05M | Buy |
+216,097
| New | +$5.05M | 0.21% | 103 |
|
|
2015
Q2 | – | Sell |
-159,585
| Closed | -$2.83M | – | 718 |
|
|
2015
Q1 | $2.83M | Buy |
+159,585
| New | +$2.83M | 0.15% | 166 |
|